Artemis Medicare Services Ratios

Artemis Medicare Services Ltd Ratios

The Artemis Medicare Services Ltd Ratios page provides a complete fundamental analysis of Artemis Medicare Services Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Artemis Medicare Services Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Artemis Medicare Services Ltd (NSE: ARTEMISMED, BSE: 542919) is currently trading at ₹228.39, with a market capitalization of ₹36.34B. As a major player in the Health services sector and Hospital/Nursing management industry, Artemis Medicare Services Ltd remains a key stock for fundamental analysis using Artemis Medicare Services Ltd Ratios.

Artemis Medicare Services Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Artemis Medicare Services Ltd P/E ratio currently stands at 51.77, making it one of the most tracked metrics in Artemis Medicare Services Ltd Ratios.

Historically, the Artemis Medicare Services Ltd P/E ratio has shown strong fluctuations:

• 2024: 51.77
• 2023: 48.12
• 2022: 24.44
• 2021: 20.06
• 2020: 45.32

The rising Artemis Medicare Services Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Artemis Medicare Services Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 4.51.

Historical P/B trend:

• 2024: 4.51
• 2023: 5.15
• 2022: 2.26
• 2021: 1.69

Artemis Medicare Services Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Artemis Medicare Services Ltd P/S ratio currently stands at 4.57, an important part of Artemis Medicare Services Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 4.57
• 2023: 2.69
• 2022: 1.28
• 2021: 1.15

The rising Artemis Medicare Services Ltd P/S ratio indicates improved revenue valuation by investors.

Artemis Medicare Services Ltd Price to Cash Flow Ratio (P/CF)

The Artemis Medicare Services Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 31.81.

Historical Artemis Medicare Services Ltd Price to Cash Flow Ratio:

• 2024: 31.81
• 2023: 27.82
• 2022: 8.37
• 2021: 12.37
• 2020: 16.11

The rising Artemis Medicare Services Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Artemis Medicare Services Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Artemis Medicare Services Ltd EV currently stands at ₹41.78B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 41.78B
• 2023: 26.3B
• 2022: 11.83B
• 2021: 8.13B

Artemis Medicare Services Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Artemis Medicare Services Ltd EV/EBITDA ratio is currently 26.93, a key metric in Artemis Medicare Services Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 26.93
• 2023: 19.56
• 2022: 12.35
• 2021: 11.97

Higher Artemis Medicare Services Ltd EV/EBITDA suggests premium valuation.

Artemis Medicare Services Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Artemis Medicare Services Ltd D/E ratio is currently 0.35, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.35
• 2023: 0.71
• 2022: 0.71
• 2021: 0.56

Artemis Medicare Services Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Artemis Medicare Services Ltd ROE currently stands at 12.85%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 12.85
• 2023: 11.54
• 2022: 10.12
• 2021: 9.36

Artemis Medicare Services Ltd maintains stable profitability levels.

Artemis Medicare Services Ltd Ratios Analysis Summary

The Artemis Medicare Services Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Artemis Medicare Services Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Artemis Medicare Services Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.